Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cytokeratin 13 anticorps

L’anticorps anti-Cytokeratin 13 Monoclonal Souris est utilisé pour la détection de Cytokeratin 13 dans des échantillons de Humain. Il a été validé pour IHC, IF et FACS.
N° du produit ABIN6939905
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Cytokeratin 13 anticorps (ABIN6939905)

Antigène

Voir toutes Cytokeratin 13 (KRT13) Anticorps
Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reactivité

  • 124
  • 51
  • 35
  • 11
  • 8
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 82
  • 44
  • 1
  • 1
Souris

Clonalité

  • 70
  • 58
Monoclonal

Conjugué

  • 75
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Cytokeratin 13 est non-conjugé

Application

  • 80
  • 63
  • 33
  • 25
  • 22
  • 21
  • 18
  • 13
  • 10
  • 9
  • 8
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

KRT13-2659
  • Fonction

    Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) Antibody

    Specificité

    Cytokeratin 13 (KRT13) is the major acidic keratin, which together with KRT4, its basic partner, is expressed in the suprabasal layers of non-cornified stratified epithelia including tongue mucosa, esophagus, anal canal epithelium, tracheal epithelium, uterine cervix, and urothelium. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder, which predominantly affects non-cornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa. KRT13 has been used as a marker for non-keratinized squamous epithelium. It is also expressed in various squamous metaplasia, but it is down regulated in squamous dysplasia and squamous carcinoma.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human KRT13 protein

    Isotype

    IgG1, kappa
  • Indications d'application

    Positive Control: HeLa or A431 cells. Skin or Squamous cell carcinoma.

    Known Application: Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

    Autre désignation

    KRT13

    Sujet

    CK13, Cytokeratin-13, Keratin Type I Cytoskeletal 13, Keratin-13, KRT13, Type I Cytoskeletal 13, WSN2

    HeLa or A431 cells. Skin or squamous cell carcinoma.

    Poids moléculaire

    52kDa

    ID gène

    3860, 654550

    UniProt

    P13646
Vous êtes ici:
Chat with us!